Status:
TERMINATED
Cytokine Change in Bronchoalveolar Lavage Fluid After Early Budesonide-Surfactant Treatment in Premature Infants
Lead Sponsor:
China Medical University Hospital
Conditions:
Premature Infants
Respiratory Distress Syndrome
Eligibility:
All Genders
1-1 years
Phase:
PHASE4
Brief Summary
Pulmonary inflammation plays an important role in the development of chronic lung disease (CLD) in preterm infants. This inflammation occurs very early in postnatal life. Any therapy that could be ben...
Detailed Description
Growing evidence suggests that early, postnatal pulmonary inflammation may play an important role in the development of chronic lung disease (CLD) in preterm infants on mechanical ventilation.The inve...
Eligibility Criteria
Inclusion
- Preterm infants with birth weight between 500-1500 gm
- Have severe radiographic RDS and require mechanical ventilation within 4 hours after birth
Exclusion
- Presence of prenatal infection, congenital anomalies and lethal cardio-pulmonary status.
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00146497
Start Date
August 1 2004
Last Update
June 27 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan